Your browser doesn't support javascript.
loading
New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
Anzola, Ana M; Trives, Laura; Martínez-Barrio, Julia; Pinilla, Blanca; Álvaro-Gracia, José María; Molina-Collada, Juan.
Affiliation
  • Anzola AM; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007, Madrid, Spain.
  • Trives L; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Martínez-Barrio J; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007, Madrid, Spain.
  • Pinilla B; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Álvaro-Gracia JM; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007, Madrid, Spain.
  • Molina-Collada J; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Clin Rheumatol ; 41(5): 1623-1625, 2022 05.
Article in En | MEDLINE | ID: mdl-35112193

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis / Vaccines / COVID-19 Limits: Humans Language: En Journal: Clin Rheumatol Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis / Vaccines / COVID-19 Limits: Humans Language: En Journal: Clin Rheumatol Year: 2022 Document type: Article Affiliation country: